Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC, 19084-19085 [2017-08347]
Download as PDF
<![CDATA[
19084
Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of, controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on August
25, 2016, Cambridge Isotope
Laboratories, 50 Frontage Road,
Andover, Massachusetts 01810 applied
to be registered as an importer of the
following basic classes of controlled
substances:
Controlled substance
Drug code
Mephedrone (4-Methyl-N-methylcathinone) ..................................................................................................................
Gamma Hydroxybutyric Acid .........................................................................................................................................
Methaqualone ................................................................................................................................................................
Lysergic acid diethylamide ............................................................................................................................................
Marihuana ......................................................................................................................................................................
Tetrahydrocannabinols ..................................................................................................................................................
3,4-Methylenedioxyamphetamine ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .....................................................................................................................
3,4-Methylenedioxymethamphetamine ..........................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ....................................................................................................
Butylone .........................................................................................................................................................................
Heroin ............................................................................................................................................................................
Pentobarbital ..................................................................................................................................................................
Secobarbital ...................................................................................................................................................................
Phencyclidine .................................................................................................................................................................
Cocaine ..........................................................................................................................................................................
Dihydrocodeine ..............................................................................................................................................................
Ecgonine ........................................................................................................................................................................
Meperidine .....................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................
Fentanyl .........................................................................................................................................................................
The company plans to import the
listed controlled substances for
analytical research, testing and clinical
trials.
Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–08346 Filed 4–24–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Siegfried
USA, LLC
asabaliauskas on DSK3SPTVN1PROD with NOTICES
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before June 26, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
SUPPLEMENTARY INFORMATION:
Drug code
Gamma Hydroxybutyric Acid .........................................................................................................................................
Dihydromorphine ............................................................................................................................................................
Hydromorphinol ..............................................................................................................................................................
Methylphenidate .............................................................................................................................................................
Amobarbital ....................................................................................................................................................................
Pentobarbital ..................................................................................................................................................................
Secobarbital ...................................................................................................................................................................
17:42 Apr 24, 2017
Jkt 241001
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
November 22, 2016, Siegfried USA,
LLC, 33 Industrial Park Road,
Pennsville, New Jersey 08070 applied to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Controlled substance
VerDate Sep<11>2014
1248
2010
2565
7315
7360
7370
7400
7404
7405
7540
7541
9200
2270
2315
7471
9041
9120
9180
9230
9273
9801
Schedule
E:\FR\FM\25APN1.SGM
25APN1
2010
9145
9301
1724
2125
2270
2315
Schedule
I
I
I
II
II
II
II
19085
Federal Register / Vol. 82, No. 78 / Tuesday, April 25, 2017 / Notices
Controlled substance
Drug code
Codeine ..........................................................................................................................................................................
Oxycodone .....................................................................................................................................................................
Hydromorphone .............................................................................................................................................................
Hydrocodone ..................................................................................................................................................................
Methadone .....................................................................................................................................................................
Methadone intermediate ................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ............................................................................................................
Morphine ........................................................................................................................................................................
Oripavine ........................................................................................................................................................................
Thebaine ........................................................................................................................................................................
Opium tincture ...............................................................................................................................................................
Oxymorphone ................................................................................................................................................................
The company plans to manufacturer
the listed controlled substances in bulk
for distribution to its customers.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before June 26, 2017.
DATES:
Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–08347 Filed 4–24–17; 8:45 am]
Drug Enforcement Administration
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
ADDRESSES:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc.
ACTION:
Notice of application.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Drug code
Cathinone .......................................................................................................................................................................
Methcathinone ...............................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ..................................................................................................................
Aminorex ........................................................................................................................................................................
Alpha-ethyltryptamine ....................................................................................................................................................
Lysergic acid diethylamide ............................................................................................................................................
Tetrahydrocannabinols ..................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................
2,5-Dimethoxyamphetamine ..........................................................................................................................................
3,4-Methylenedioxyamphetamine ..................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .....................................................................................................................
3,4-Methylenedioxymethamphetamine ..........................................................................................................................
Dimethyltryptamine ........................................................................................................................................................
Psilocybin .......................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .............................................................................................................................
N-Benzylpiperazine ........................................................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .....................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ....................................................................................................
Heroin ............................................................................................................................................................................
Normorphine ..................................................................................................................................................................
Norlevorphanol ...............................................................................................................................................................
Amphetamine .................................................................................................................................................................
Methamphetamine .........................................................................................................................................................
Nabilone .........................................................................................................................................................................
1-Phenylcyclohexylamine ..............................................................................................................................................
Phencyclidine .................................................................................................................................................................
Cocaine ..........................................................................................................................................................................
Codeine ..........................................................................................................................................................................
Ecgonine ........................................................................................................................................................................
17:42 Apr 24, 2017
Jkt 241001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
December 19, 2016, Sigma Aldrich
Research Biochemicals, Inc., 1–3
Strathmore Road, Natick, Massachusetts
01760–2447 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
VerDate Sep<11>2014
9050
9143
9150
9193
9250
9254
9273
9300
9330
9333
9630
9652
Schedule
E:\FR\FM\25APN1.SGM
25APN1
1235
1237
1248
1585
7249
7315
7370
7391
7392
7395
7396
7400
7402
7404
7405
7435
7437
7439
7470
7493
7535
7540
9200
9313
9634
1100
1105
7379
7460
7471
9041
9050
9180
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 82, Number 78 (Tuesday, April 25, 2017)]
[Notices]
[Pages 19084-19085]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08347]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Siegfried
USA, LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before June 26, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
November 22, 2016, Siegfried USA, LLC, 33 Industrial Park Road,
Pennsville, New Jersey 08070 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid........... 2010 I
Dihydromorphine..................... 9145 I
Hydromorphinol...................... 9301 I
Methylphenidate..................... 1724 II
Amobarbital......................... 2125 II
Pentobarbital....................... 2270 II
Secobarbital........................ 2315 II
[[Page 19085]]
Codeine............................. 9050 II
Oxycodone........................... 9143 II
Hydromorphone....................... 9150 II
Hydrocodone......................... 9193 II
Methadone........................... 9250 II
Methadone intermediate.............. 9254 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine............................ 9300 II
Oripavine........................... 9330 II
Thebaine............................ 9333 II
Opium tincture...................... 9630 II
Oxymorphone......................... 9652 II
------------------------------------------------------------------------
The company plans to manufacturer the listed controlled substances
in bulk for distribution to its customers.
Dated: April 18, 2017.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017-08347 Filed 4-24-17; 8:45 am]
BILLING CODE 4410-09-P
